| | THE STATE OF THE DRUGS PROBLEM IN THE EUROPEAN UNION AND |
| | 1,91 | | MB | NORWAY |
| | 120 | | stron |
| | 5822 | | ID | European Monitoring Centre for Drugs and Drug Addiction |
| | 2004 | | rok |
| | Contents |
| | Foreword 5 |
| | Acknowledgements 7 |
| | Introductory note 7 |
| | At a glance — an overview of the European drug situation 9 |
| | Chapter 1 |
| | New developments in policies and laws 15 |
| | Chapter 2 |
| | Drug prevention — working with communities and targeting those most at risk 24 |
| | Chapter 3 |
| | Cannabis 28 |
| | Chapter 4 |
| | Amphetamine-type stimulants, LSD and other synthetic drugs 34 |
| | Chapter 5 |
| | Cocaine and crack cocaine 44 |
| | Chapter 6 |
| | Heroin and injecting drug use 50 |
| | Chapter 7 |
| | Treatment — meeting the needs of those with problems 63 |
| | Chapter 8 |
| | Crime and prison issues 70 |
| | Selected issue 1 |
| | Evaluation of ‘national drugs strategies’ in Europe 75 |
| | Selected issue 2 |
| | Cannabis problems in context — understanding the increase in European treatment demands 82 |
| | Selected issue 3 |
| | Co-morbidity 94 |
| | References 105 |
| | Reitox focal points 111 |